149 related articles for article (PubMed ID: 38415555)
21. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
22. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
Prueksaritanond N; Chantape W
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
[TBL] [Abstract][Full Text] [Related]
23. Lung Cancer Survival with Current Therapies and New Targeted Treatments: A Comprehensive Update from the Srinagarind Hospital-Based Cancer Registry from (2013 to 2017).
Musika W; Kamsa-Ard S; Jirapornkul C; Santong C; Phunmanee A
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2501-2507. PubMed ID: 34452564
[TBL] [Abstract][Full Text] [Related]
24. [Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].
Gottwald L; Chałubińska J; Moszyńska-Zielińska M; Piekarski J; Tyliński W; Szwalski J; Kubiak R; Pasz-Walczak G; Hendzel K; Ciałkowska-Rysz A
Ginekol Pol; 2011 Oct; 82(10):743-8. PubMed ID: 22379937
[TBL] [Abstract][Full Text] [Related]
25. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
26. Patterns of adjuvant therapy for endometrial cancer: single institutional experience in Thailand.
Tangjitgamol S; Khunnarong J; Katanyoo K; Srijaipracharoen S; Thavaramara T; Pataradool K
Int J Gynecol Cancer; 2015 May; 25(4):665-72. PubMed ID: 25664438
[TBL] [Abstract][Full Text] [Related]
27. Incidence and clinical outcomes of non-endometrioid carcinoma of endometrium: Siriraj Hospital experience.
Jaishuen A; Kunakornporamat K; Viriyapak B; Benjapibal M; Chaopotong P; Petsuksiri J; Therasakvichya S
Asian Pac J Cancer Prev; 2014; 15(6):2905-9. PubMed ID: 24761923
[TBL] [Abstract][Full Text] [Related]
28. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
29. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Waiting Time-to-Surgery on Survival in Endometrial Cancer Patients.
Plubprasit J; Sukkasame P; Bhamarapravatana K; Suwannarurk K
Asian Pac J Cancer Prev; 2024 Jan; 25(1):95-101. PubMed ID: 38285772
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
Chapman BV; Swanick CW; Ning MS; Allen PK; Soliman PT; Westin SN; Pardeshi V; Broaddus RR; Lu KH; Jhingran A; Eifel PJ; Klopp AH
Gynecol Oncol; 2019 Jul; 154(1):22-28. PubMed ID: 31109659
[TBL] [Abstract][Full Text] [Related]
32. Non-exenterative surgical management of recurrent endometrial carcinoma.
Moukarzel LA; Braxton KF; Zhou QC; Pedra Nobre S; Iasonos A; Alektiar KM; Tew WP; Abu-Rustum NR; Leitao MM; Chi DS; Mueller JJ
Gynecol Oncol; 2021 Aug; 162(2):268-276. PubMed ID: 34090704
[TBL] [Abstract][Full Text] [Related]
33. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of squamous differentiation in endometrioid type endometrial cancer: a matched analysis.
Aslan K; Öz M; Ersak B; Müftüoğlu HK; Moraloğlu Tekin Ö; Meydanli MM
J Obstet Gynaecol; 2022 Apr; 42(3):494-500. PubMed ID: 34155955
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of Treatment, Survival Rates, and Factors related to Survival of Stage III Lung Cancer Patients Treated at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Thailand.
Raksasri N; Kamsa-Ard S; Musika W; Santong C; Phunmanee A
Asian Pac J Cancer Prev; 2023 May; 24(5):1743-1749. PubMed ID: 37247297
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
[TBL] [Abstract][Full Text] [Related]
37. Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand.
Tangjitgamol S; Khunnarong J; Srijaipracharoen S
J Gynecol Oncol; 2015 Oct; 26(4):293-302. PubMed ID: 26197770
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
39. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
40. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]